hypertension
(7)
CORXEL Pharmaceuticals
CORXEL Pharmaceuticals is a clinical-stage biopharmaceutical company developing innovative therapies for cardiometabolic diseases worldwide. Spun out of RTW Investments in 2019 (formerly JiXing Pharmaceuticals) and dual-based in Berkeley Heights, New Jersey and Shanghai, CORXEL is advancing a pipeline led by CX11, a differentiated oral small-molecule GLP-1 receptor agonist for obesity and type 2 diabetes, alongside JX10 for acute ischemic stroke and JX09 for hypertension. In January 2026 the company raised up to $287 million in Series D1 financing to push these programs through late-stage clinical trials.
Cadence
Cadence is a New York-based clinical technology company that helps health systems deliver continuous, proactive care to patients with chronic conditions at home. It pairs FDA-cleared connected devices that track vitals with an AI-powered care platform and a 24/7 clinical team, so doctors can catch problems - rising blood pressure, fluid buildup, glucose swings - before they become emergencies. Cadence partners with more than 20 leading U.S. health systems and supports tens of thousands of patients across dozens of states, targeting chronic diseases such as heart failure, hypertension, type 2 diabetes, and COPD.
QURA, Inc.
QURA, Inc. is a preclinical medical-technology company in Massachusetts building a tiny implanted sensor that continuously measures blood pressure and wirelessly transmits medical-grade waveform data to patients and physicians in real time. Its QSmart platform - a vitamin-sized QSense implant paired with software and analytics - aims to replace the occasional cuff reading with always-on monitoring, targeting hypertension, the leading cardiovascular risk factor worldwide. The technology grew out of an earlier wireless implantable pressure sensor developed for glaucoma (intraocular pressure) monitoring.
Omada Health
Omada Health is a publicly traded (Nasdaq: OMDA) virtual chronic care company that uses behavioral science, connected devices, AI tools, and human care teams to help people manage prediabetes, diabetes, hypertension, high cholesterol, musculoskeletal conditions, and weight - including support for members on GLP-1 medications. Founded in 2011 in San Francisco, it sells to employers, health plans, and pharmacy benefit managers, serving roughly 2,000-plus customers and more than 886,000 members.
Vida Health
Vida Health is a San Francisco-based digital health company that pairs an AI-powered, personalized app with human coaches, dietitians, therapists, and physicians to prevent, manage, and reverse chronic physical and mental conditions. Its virtual cardiometabolic clinic treats obesity, diabetes, hypertension, and the depression and anxiety that travel with them, and is sold to employers and health plans as a clinically validated, cost-managed alternative to fragmented point solutions, including responsible GLP-1 prescribing.
Hello Heart
Hello Heart is a Menlo Park-based digital health company exclusively focused on cardiovascular health. Founded in 2013, it offers an AI-powered mobile app paired with a connected blood pressure monitor and smart pill box that helps members understand, track, and improve their heart health. Deployed through employers, health plans, and Medicare Advantage programs, Hello Heart has served users at 150+ Fortune 500 companies and government organizations. Independent peer-reviewed studies - including a JAMA study of 28,000+ participants - show that 84% of high-risk users reduced blood pressure over three years, with average medical cost savings exceeding $1,700 per enrolled member per year. The company has raised $148.5 million in total funding, most recently a $70 million Series D in May 2022.
Lark Health
Lark Health is a Mountain View-based digital health company that delivers 24/7, AI-powered nurse coaching for chronic conditions - diabetes, hypertension, weight, behavioral health and tobacco cessation - through a text-message-style app paired with connected devices. Built on cognitive behavioral therapy and used by major payers, Lark scales personalized care to tens of millions of covered lives.